ARALEZ PHARMACEUTICALS INC's ticker is ARLZ and the CUSIP is 03852X100. A total of 84 filers reported holding ARALEZ PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 3.96 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $0 | -100.0% | 100 | -99.7% | 0.00% | – |
| Q1 2018 | $47,000 | -13.0% | 31,242 | -18.5% | 0.00% | – |
| Q4 2017 | $54,000 | +5300.0% | 38,342 | +9485.5% | 0.00% | – |
| Q2 2017 | $1,000 | -98.6% | 400 | -98.8% | 0.00% | – |
| Q1 2017 | $69,000 | +666.7% | 32,229 | +1330.5% | 0.00% | – |
| Q4 2016 | $9,000 | -25.0% | 2,253 | -39.3% | 0.00% | – |
| Q2 2016 | $12,000 | – | 3,713 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 2,737,140 | $9,033,000 | 7.18% |
| DRILL CRAIG A | 584,600 | $1,929,000 | 3.80% |
| ARMISTICE CAPITAL, LLC | 2,664,000 | $8,791,000 | 3.35% |
| Healthcare Value Capital, LLC | 575,000 | $1,898,000 | 2.30% |
| Tiger Legatus Capital Management, LLC | 1,500,000 | $4,950,000 | 1.50% |
| Broadfin Capital, LLC | 4,106,990 | $13,553,000 | 1.32% |
| Kavi Asset Management, LP | 313,627 | $1,035,000 | 0.83% |
| Elk Creek Partners, LLC | 1,514,918 | $4,999,000 | 0.36% |
| Par Capital Management | 6,400,000 | $21,120,000 | 0.35% |
| Healthcare Value Capital, LLC | 75,000 | $248,000 | 0.30% |